| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.50B | 29.14B | 24.92B | 23.77B | 23.06B | 21.93B |
| Gross Profit | 7.46B | 9.01B | 6.98B | 6.68B | 6.52B | 7.62B |
| EBITDA | 2.90B | 3.11B | 1.89B | 2.66B | 1.69B | 3.10B |
| Net Income | 535.81M | 1.83B | 101.13M | 948.71M | 1.59B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 32.24B | 47.27B | 32.49B | 32.25B | 31.35B | 27.66B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 3.88B | 3.31B | 3.51B | 2.99B | 3.33B |
| Total Debt | 4.07B | 11.33B | 4.85B | 4.66B | 5.67B | 2.66B |
| Total Liabilities | 8.08B | 20.47B | 8.02B | 8.23B | 8.86B | 6.81B |
| Stockholders Equity | 24.10B | 26.46B | 24.41B | 23.99B | 22.46B | 20.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.06B | 564.48M | 1.76B | -3.12B | -250.08M |
| Operating Cash Flow | 0.00 | 2.30B | 2.46B | 3.41B | -1.59B | 1.89B |
| Investing Cash Flow | 0.00 | -4.94B | -1.98B | -1.63B | -1.93B | -1.86B |
| Financing Cash Flow | 0.00 | 3.03B | -672.18M | -1.30B | 2.99B | 867.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
65 Neutral | ¥7.93B | 4.20 | ― | 1.66% | 16.91% | 1710.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | ¥10.78B | -3.79 | ― | 4.41% | 3.61% | -9713.46% | |
43 Neutral | ¥8.01B | -5.48 | ― | 2.65% | 1.29% | -181.94% |